Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSC | P53634 | 18/20 | 0.48 |
| ▸ | CTSK | P43235 | 6/20 | 0.48 |
| ▸ | CTSS | P25774 | 2/20 | 0.43 |
| ▸ | CTSB | P07858 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19858731 | 1.00 | CTSC (0.48) | CTSCCTSKCTSSCTSB | |
| SCHEMBL29455637 | 0.87 | CTSC (0.52) | CTSCCTSK | |
| SCHEMBL19858724 | 0.87 | CTSC (0.45) | CTSCCTSK | |
| SCHEMBL19858725 | 0.87 | CTSC (0.45) | CTSCCTSK | |
| SCHEMBL16064465 | 0.85 | CTSC (0.63) | CTSCCTSKCTSS | |
| SCHEMBL30738857 | 0.82 | CTSK (0.49) | CTSCCTSKCTSSCTSB | |
| SCHEMBL28700450 | 0.82 | CTSC (0.67) | CTSCCTSK | |
| SCHEMBL29578917 | 0.82 | CTSC (0.67) | CTSCCTSK | |
| SCHEMBL24981063 | 0.82 | CTSC (0.47) | CTSCCTSK | |
| SCHEMBL16064206 | 0.81 | CTSC (0.65) | CTSCCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807635-B2 | Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof | HAISCO PHARMACEUTICALS PTE. LTD. (SG) | 2023-11-07 | — | — | US | disclosed |
| US-11807635-B2 | Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof | HAISCO PHARMACEUTICALS PTE. LTD. (SG) | 2023-11-07 | — | — | US | disclosed |
| US-20230121807-A1 | NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF | HAISCO PHARMACEUTICALS PTE. LTD (SG) | 2023-04-20 | — | — | US | disclosed |
| EP-4129989-A1 | NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF | Haisco Pharmaceuticals Pte. Ltd. (SG) | 2023-02-08 | — | — | EP | disclosed |
| WO-2022042591-A1 | NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF | 四川海思科制药有限公司 | 2022-03-03 | — | — | WO | disclosed |
| EP-3265452-B1 | PEPTIDYL NITRIL COMPOUNDS AS DIPEPTIDYL PEPTIDASE I INHIBITORS | Neuprozyme Therapeutics ApS (DK) | 2020-03-04 | — | — | EP | disclosed |
| US-10479781-B2 | Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors | Neuprozyme Therapeutics ApS (DK) | 2019-11-19 | — | — | US | disclosed |
| US-20180044328-A1 | PEPTIDYL NITRIL COMPOUNDS AS DIPEPTIDYL PEPTIDASE I INHIBITORS | PROZYMEX A/S (DK) | 2018-02-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11807635-B2 | Nitrile derivative that acts as inhibitor of dipeptidyl peptidase 1 and use thereof | DPP4, DPP3, DPP9 | CTSC 4/4885CTSK 454/4885CTSS 292/4885 |
| US-10479781-B2 | Peptidyl nitril compounds as dipeptidyl peptidase I inhibitors | DPP4, DPP3, DPP8 | CTSC 7/4885CTSK 261/4885CTSS 444/4885 |
| US-20180044328-A1 | PEPTIDYL NITRIL COMPOUNDS AS DIPEPTIDYL PEPTIDASE I INHIBITORS | DPP4, DPP3, DPP8 | CTSC 7/4885CTSK 237/4885CTSS 326/4885 |
| US-20230121807-A1 | NITRILE DERIVATIVE THAT ACTS AS INHIBITOR OF DIPEPTIDYL PEPTIDASE 1 AND USE THEREOF | DPP4, DPP3, DPP9 | CTSC 4/4885CTSK 454/4885CTSS 292/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.